COST-EFFECTIVENESS OF SWITCHING STRATEGIES FROM A 7-VALENT TO A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE

被引：1
|
作者：
Claes, C. [1 ]
Mittendorf, T. [1 ]
Kuchenbecker, U. [2 ]
Rose, M. [3 ]
Reinert, R. R. [4 ]
机构：
[1] Leibniz Univ Hannover, Hannover, Germany
[2] Wyeth Pharma, Munster, Germany
[3] Goethe Univ Frankfurt, Frankfurt, Germany
[4] Wyeth Vaccines Res, Paris, France
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75100-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A425 / A425
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Jaime E Ordóñez
    John J Orozco
    [J]. BMC Infectious Diseases, 14
  • [22] THE COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE IN CHINA: A MARKOV MODEL
    Fu, Y.
    Liu, G. G.
    Ma, A.
    Zhu, L.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A93 - A93
  • [23] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Ordonez, Jaime E.
    Orozco, John J.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [24] Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
    Steens, Anneke
    Bergsaker, Marianne A. Riise
    Aaberge, Ingeborg S.
    Ronning, Karin
    Vestrheim, Didrik F.
    [J]. VACCINE, 2013, 31 (52) : 6232 - 6238
  • [25] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [26] Cost-effectiveness of pneumococcal vaccination (PCV) for infants with the 7-valent pneumococcal conjugate vaccine in Hong Kong
    Lee, K. K.
    Lee, V. W. Y.
    Hon, E. K.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A164 - A164
  • [27] The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    van Hoek, Albert Jan
    Choi, Yoon Hong
    Trotter, Caroline
    Miller, Elizabeth
    Jit, Mark
    [J]. VACCINE, 2012, 30 (50) : 7205 - 7213
  • [28] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Mark Atwood
    Linda Beausoleil
    Marie-Claude Breton
    Craig Laferriere
    Reiko Sato
    Derek Weycker
    [J]. Canadian Journal of Public Health, 2018, 109 : 756 - 768
  • [29] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Atwood, Mark
    Beausoleil, Linda
    Breton, Marie-Claude
    Laferriere, Craig
    Sato, Reiko
    Weycker, Derek
    [J]. CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2018, 109 (5-6): : 756 - 768
  • [30] Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions
    Cho, Bo-Hyun
    Stoecker, Charles
    Link-Gelles, Ruth
    Moore, Matthew R.
    [J]. VACCINE, 2013, 31 (50) : 6011 - 6021
12345